Progress of molecular targeted therapies for advanced renal cell carcinoma.
about
Therapeutic challenges in renal cell carcinomaIs carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma.Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma.A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective studyEffect of Akti-2 on sperm motility, capacitation and acrosome reaction in a mouse modelPreclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma.Application of the American Society of Clinical Oncology frameworks to compare tyrosine kinase inhibitors used in first line treatment of metastatic renal cell carcinoma: Had we solved the mystery?Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Assessment of response to anti-angiogenic targeted therapy in pulmonary metastatic renal cell carcinoma: R2* value as a predictive biomarker.Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma.Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
P2860
Q26796702-1A085FB0-3FEE-4748-8E5A-0FB157E9BAD9Q26849504-87BE5754-86A8-4372-8648-607987168547Q35236736-AF0575E7-C4FD-49AE-ACE0-B136982A4E29Q36255816-B7889D5A-883C-450E-9A12-F77387049286Q36287386-AFF2608A-C49E-498F-B50C-9C44F5BCFD16Q36546814-7F95F078-5AE4-4433-A150-C1FF4EFDC23BQ36824601-D58D0204-1A7D-471C-8A92-6E1C57F9C106Q38201328-CFA4A3E0-D4C3-4596-8EC7-7C441F6F6213Q38598277-145A74F2-6F33-4795-8AC5-83897397EDBAQ39390859-889F7B11-C298-4661-98D6-C8269220E47EQ50927457-8E82243C-FD10-4689-994B-0EA3A50864E6Q53663337-E32FF583-4154-42B2-99B3-4993C677793BQ59136865-87DAD94C-6766-477E-8582-57984F2A442D
P2860
Progress of molecular targeted therapies for advanced renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Progress of molecular targeted therapies for advanced renal cell carcinoma.
@en
type
label
Progress of molecular targeted therapies for advanced renal cell carcinoma.
@en
prefLabel
Progress of molecular targeted therapies for advanced renal cell carcinoma.
@en
P2093
P2860
P50
P921
P356
P1476
Progress of molecular targeted therapies for advanced renal cell carcinoma
@en
P2093
Consuelo Amantini
Giorgio Santoni
Giovanni Muzzonigro
Luciano Burattini
Matteo Santoni
P2860
P304
P356
10.1155/2013/419176
P407
P5008
P577
2013-09-04T00:00:00Z